Navigation Links
New Survey Shows Seniors Overwhelmingly Satisfied With Medicare Part D
Date:11/18/2008

92% Satisfaction Rate with Medicare Drug Coverage

RESTON, Va., Nov. 18 /PRNewswire-USNewswire/ -- Ninety-two percent of seniors enrolled in the Medicare Part D prescription drug benefit in 2008 are satisfied with their coverage according to a national phone survey by RetireSafe, a nationwide education and advocacy group for older Americans.

The findings were not unexpected. Similar surveys conducted over the last year found the same results. "The universal high rates of satisfaction across all of the surveys prove that the program is working well for the vast majority of seniors," said RetireSafe President Michelle Plasari in announcing the results of the latest survey.

The survey also indicated that ninety percent of seniors were happy with the number of medicines their individual plan covered, and eighty-five percent felt their overall costs were manageable. Eighty-one percent of seniors said that they would most likely stick with their current drug plan for the coming year.

Some key results include:

  • Almost all (96%) of seniors surveyed reported that their Medicare drug plan was relatively easy to use.
  • Importantly, 86 percent reported that they no longer needed to skip doses or cut their pills now that they are enrolled in Part D.
  • Nearly all (95%) said that they were satisfied that they were getting the medicines they needed through their Part D plan.
  • Eighty-nine percent reported that they now had the peace of mind of knowing they could afford the medicines they needed.
  • Finally, the survey also found out that 91 percent of seniors agreed with the statement that "My Medicare plan is working for me and I am happy I signed up."

"The results of the survey send a clear message -- seniors are happy with their Medicar
'/>"/>

SOURCE RetireSafe
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Epocrates Survey Identifies Trends in Online Resource Use Among Physicians
2. Consumers Weigh in on Which TV Doc They Would Want as Their Own:Survey Results from the American Board of Medical Specialties Find Dr. House Most Loved/Hated TV Doctor
3. Lumension Uncovers Results of Security Data Protection Survey
4. More Than Half of Consumers Going to Doctors Less Due to Rising Healthcare Costs, According to checkMD Survey : 38 Percent Lack Adequate Employer Healthcare Coverage
5. Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues.
6. New survey: More than half of US chronically ill adults skip needed care due to costs
7. AMN Survey: Nurses to Have Bigger Impact on Hospital Revenue
8. Consumer Reports Survey: Nearly Half of Adults Wont Get Flu Vaccine, Citing Poor Excuses Like I Dont Get Sick
9. New Survey Indicates "Highest-Value" Physicians Most Likely to Participate in Aptilons Live Video Detailing Service
10. Ford Motor Co. Tops First-Ever Healthcare Purchasing Power Survey
11. Survey finds widespread dissatisfaction with current health care payment system

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... 9 Speaker Nancy Pelos...ions in the Affordable Health Care for America ...aid and reduce Medicare Part D costs for people li...Saturday by a vote of 220 to 215: ,, "Effectiv...ality of life for thousands of Americans living wi...
(Date:11/9/2009)...e, Nov. 9 At a time when the 250,0...easingly concerned about finding affordable health...ption for 2010. ,, The Today,s Options® Pr...tage plan provides a cost-effective and comprehens... Supplement plan. People with Medicare can choose...
(Date:11/9/2009)... 9 The American Academy... than 75,000 clinically practicing physician assis...uds the U.S. House of Representatives for passing ...he Affordable Health Care for America Act. ,, "...will ultimately lower the cost of health care and ...
(Date:11/9/2009)...Research Hospital and the University of Florida Pr... to provide proton therapy for St. Jude patients. ... clinical study to evaluate the use of proton ther...n 3 years old. , Under the clinical protocol, ...rapy at the UF Proton Therapy Institute in Jackson...
(Date:11/9/2009)...er 9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), t...ay announced the availability of INTUNIV (guanfaci...the United States for the treatment of Attention-D...nd adolescents ages 6 to 17. INTUNIV, a once-dail... nonscheduled alpha-2A receptor agonist approved f...
Breaking Medicine News(10 mins):Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4
...ustralians face increasingly large-scale,health ri...onment, ranging from,increases in weather extremes...health., Twelve of Australias top health and medic...ustralians., Released today by Research Australia,...
...research tracks the spread of HIV from Africa to A...s) -- New research into the genetic history of HIV...in Haiti during the middle of the last century, pr... into how HIV evolves and moves from place to plac...
...N, Pa., Oct. 30 ViroPharma Incorporated,(Nasdaq: ...he third quarter,and nine-months ended September 3... Clinical:, -- Patient enrollment began in a Pha...stem cell transplant patients; study enrollment ex...
...es Fiscal Year EPS Outlook for One-time Tax Benefi...e Company (NYSE: PG ) announced net sales growth ... Every reportable segment delivered,mid-single dig... Fabric & Home Care, Baby & Family Care and Groomi...
...CETON, N.J., Oct. 30 Medarex, Inc.,(Nasdaq: MEDX... at the,JPMorgan Small/Mid Cap Conference in Bosto...Time. Medarex,s presentation will be webcast live ...arex.com . About Medarex Medarex is a biopharmac...
...JOSEPH, Mich., Oct. 30 GeneGo, Inc., the leading,...t Elan Pharmaceuticals,Inc. licensed its flagship ...l be available to all scientists in research. Meta... very pleased that Elan chose GeneGo and we have h...
Other Medicine News:Health News:Healthy planet, places and people at risk 2Health News:AIDS Stopped in Haiti Before U.S. 2Health News:AIDS Stopped in Haiti Before U.S. 3Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 2Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 3Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 4Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 5Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 6Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 7Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 8Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 9Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 10Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 2Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 3Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 4Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 5Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 6Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 7Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 8Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 9Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 10Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 11Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 12Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 13Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 14Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 15Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 16
(Date:11/9/2009)...ROCKVILLE, Md., Nov. 9 OriGene Tec... Technology in Sweden has adopted its VERIFY Tagge...an Protein Atlas program. This program is funded b...set up to explore the human proteome systematicall...h quality mono-specific antibodies in a high throu...
(Date:11/9/2009)...ST. LOUIS, Nov. 9, 2009 ...E: PFE ) today announced that they have entered i...Chesterfield Village Research Center located in Ch... Monsanto will acquire the property from Pfizer fo...ll continue to have operations at Chesterfield Vil...
(Date:11/9/2009)...VIRGINIA BEACH, Va., Nov. 9 LifeNe... announces the launch of Vertigraft Cervical Bio-I..., Preservon® is a new, proprietary glycerol-b...io-implants to be stored in a fully hydrated state...to freeze or freeze-dry bio-implants, doing away w...
Breaking Medicine Technology:Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 3LifeNet Health Announces First Bio-Implant with New Preservation Technology 2Gene Therapy Shows Promise for Parkinsons 59471 1Gene Therapy Shows Promise for Parkinsons 59471 2Gene Therapy Shows Promise for Parkinsons 59471 3Experts Summarize State of the Science in Autism Disorders 59468 1Experts Summarize State of the Science in Autism Disorders 59468 2Experts Summarize State of the Science in Autism Disorders 59468 3Experts Summarize State of the Science in Autism Disorders 59468 4Jack LaLanne Celebrated as Fitness Icon at Star Studded Birthday Bash 59465 1Jack LaLanne Celebrated as Fitness Icon at Star Studded Birthday Bash 59465 2
...antly Reduced Signs of Disease Activity as Measure..., 2007 -- Genentech, Inc.,(NYSE: DNA) and Biogen... data from a Phase II clinical study of Rituxan&re...g multiple sclerosis,(RRMS) were presented today a... held in Boston. Rituxan is a therapeutic antibody...
...tzerland, May 2, 2007 – Merck,Serono S.A. (v...,safinamide, a new agent in Phase III development ...ptoms, were presented by Professor,Fabrizio Stocch...,Meeting in Boston, Massachusetts, USA. These data... blind, placebo-controlled,international trial. ,...
Other Medicine Technology:Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 2Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 3Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 4Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 5
VitalWorks Intuition PM Ophthalmology
...ITER Electronic Medical Records (including ExamDRA... record instrument in the industry. Doctors and st...effortless speed and accuracy using our trademarke...ed for typing, we have created the fastest, easies...
Simplex™ P Bone Cement
...1 Gentamicin Bone Cement, a high viscosity antibio...ional market for over a decade, eliminates the inc...e premixed powder helps to prevent inconsistency i...cin Bone Cement provides the same proven character...
Medicine Products: